Mdm2 promotes the rapid degradation of p53

Haupt, Ygal, Maya, Ruth, Kazaz, Anat, Oren, Moshe·1997·Nature
DOI 10.1038/387296a0

Cited by (1,058)

Items 201–300 of 1,058

  1. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
    Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, Won Fen Wong, Gautam Sethi, Chung Yeng Looi · 2019 · Frontiers in Oncology
  2. Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53
    Yanping Zhang, Yue Xiong · 1999 · Molecular Cell
  3. Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation
    Constantinos Koumenis, Rodolfo M. Alarcon, Ester M. Hammond, Patrick D. Sutphin, William Hoffman, Maureen E. Murphy, Jennifer L. Derr, Yoichi Taya, Scott W. Lowe, Michael B. Kastan et al. · 2001 · Molecular and Cellular Biology
  4. The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
    Manfredi, James J. · 2010 · Genes & Development
  5. ERKs and p38 Kinase Phosphorylate p53 Protein at Serine 15 in Response to UV Radiation
    Qing‐Bai She, Nanyue Chen, Zigang Dong · 2000 · Journal of Biological Chemistry
  6. A dual role of p53 in the control of autophagy
    Ezgi Tasdemir, Maria Chiara Maiuri, Eugenia Morselli, Alfredo Criollo, Marcello D’Amelio, Mojgan Djavaheri‐Mergny, Francesco Cecconi, Nektarios Tavernarakis, Guido Kroemer · 2008 · Autophagy
  7. JNK targets p53 ubiquitination and degradation in nonstressed cells
    Serge Yu. Fuchs, Victor Adler, Thomas Buschmann, Zhimin Yin, Xiangwei Wu, Stephen N. Jones, Ze’ev A. Ronai · 1998 · Genes & Development
  8. Autophagy
    Amber N. Hale, Daniel Ledbetter, Thomas R. Gawriluk, Edmund B. Rucker · 2013 · Autophagy
  9. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
    Boyd, Scott D., Tsai, Kenneth Y., Jacks, Tyler · 2000 · Nature Cell Biology
  10. MDM2 suppresses p73 function without promoting p73 degradation
    Zeng, Xiaoya, Chen, Lihong, Jost, Christine A., Maya, Ruth, Keller, David, Wang, Xinjiang, Kaelin, William G., Oren, Moshe, Chen, Jiandong, Lu, Hua · 1999 · Molecular and Cellular Biology
  11. p53 Acetylation: Regulation and Consequences
    Sara M. Reed, Dawn E. Quelle · 2014 · Cancers
  12. DNA microarrays identification of primary and secondary target genes regulated by p53
    Karuppiah Kannan, Ninette Amariglio, Gideon Rechavi, Jasmine Jacob‐Hirsch, Itai Kela, Naftali Kaminski, Gad A. Getz, Eytan Domany, David Givol · 2001 · Oncogene
  13. The p53 tumor suppressor participates in multiple cell cycle checkpoints
    Luciana E. Giono, James J. Manfredi · 2006 · Journal of Cellular Physiology
  14. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    D H Kim, Heather H. Nelson, John K. Wiencke, Shichun Zheng, David C. Christiani, John C. Wain, Eugene Jerome Mark, Karl T. Kelsey · 2001 · PubMed
  15. MDM2 interacts with MDMX through their RING finger domains
    Tanimura, Shyu, Ohtsuka, Satoshi, Mitsui, Kaoru, Shirouzu, Kazuo, Yoshimura, Akihiko, Ohtsubo, Motoaki · 1999 · FEBS Letters
  16. Hypoxia Links ATR and p53 through Replication Arrest
    Ester M. Hammond, Nicholas C. Denko, Mary Jo Dorie, Robert T. Abraham, Amato J. Giaccia · 2002 · Molecular and Cellular Biology
  17. The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
    Jianhui Zhu, Jieyuan Jiang, Wenjing Zhou, Xinbin Chen · 1998 · PubMed
  18. Stimulus‐dependent dynamics of p53 in single cells
    Eric Batchelor, Alexander Loewer, Caroline S. Mock, Galit Lahav · 2011 · Molecular Systems Biology
  19. Clinical Overview of MDM2/X-Targeted Therapies
    Burgess, Andrew, Chia, Kee Ming, Haupt, Sue, Thomas, David, Haupt, Ygal, Lim, Elgene · 2016 · Frontiers in Oncology
  20. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
    Barbara Marengo, Mariapaola Nitti, Anna Lisa Furfaro, Renata Colla, Chiara De Ciucis, Umberto Maria Marinari, Maria Adelaide Pronzato, Nicola Traverso, Cinzia Domenicotti · 2016 · Oxidative Medicine and Cellular Longevity
  21. Allele-Specific p53 Mutant Reactivation
    Xin Yu, Alexei Vázquez, Arnold J. Levine, Darren R. Carpizo · 2012 · Cancer Cell
  22. Structural Mechanism of the Bromodomain of the Coactivator CBP in p53 Transcriptional Activation
    Shiraz Mujtaba, Yan He, Lei Zeng, Sherry X. Yan, Olga V. Plotnikova, Sachchidanand, Roberto Sánchez, Nancy J. Zeleznik‐Le, Ze’ev A. Ronai, Ming‐Ming Zhou · 2004 · Molecular Cell
  23. Regulation of p53 Function
    Douglas B. Woods, Karen H. Vousden · 2001 · Experimental Cell Research
  24. p53, Oxidative Stress, and Aging
    Dongping Liu, Yang Xu · 2010 · Antioxidants and Redox Signaling
  25. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
    Gad Asher, Joseph Lotem, Batya Cohen, Leo Sachs, Yosef Shaul · 2001 · Proceedings of the National Academy of Sciences
  26. The p53 family and programmed cell death
    E. Christine Pietsch, Stephen Matthew Sykes, Steven B. McMahon, Maureen E. Murphy · 2008 · Oncogene
  27. Activation and activities of the p53 tumour suppressor protein
    Éva Bálint, Karen H. Vousden · 2001 · British Journal of Cancer
  28. p53 stabilization is decreased upon NFκB activation
    Vinay Tergaonkar, Matthew P. Pando, Omid Vafa, Geoffrey M. Wahl, Inder M. Verma · 2002 · Cancer Cell
  29. Emerging biomarkers in head and neck cancer in the era of genomics
    Hyunseok Kang, Ana P. Kiess, Christine H. Chung · 2014 · Nature Reviews Clinical Oncology
  30. MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
    Gareth L. Bond, Wenwei Hu, Arnold J. Levine · 2005 · Current Cancer Drug Targets
  31. Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
    Naihan Xu, Yuanzhi Lao, Yaou Zhang, David A. Gillespie · 2012 · Journal of Oncology
  32. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
    Astle, M V, Hannan, K M, Ng, P Y, Lee, R S, George, A J, Hsu, A K, Haupt, Y, Hannan, R D, Pearson, R B · 2012 · Oncogene
  33. Misregulation of Pre-mRNA Alternative Splicing in Cancer
    Jian Zhang, James L. Manley · 2013 · Cancer Discovery
  34. Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
    David C. Corney, Chang‐Il Hwang, Andrés Matoso, Markus Vogt, Andrea Flesken‐Nikitin, Andrew K. Godwin, Aparna A. Kamat, Anil K. Sood, Lora Hedrick Ellenson, Heiko Hermeking et al. · 2010 · Clinical Cancer Research
  35. Proteolytic Cleavage of Human p53 by Calpain: a Potential Regulator of Protein Stability
    Michael H.G. Kubbutat, Karen H. Vousden · 1997 · Molecular and Cellular Biology
  36. p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
    Yili Yin, Charles W. Stephen, Maria Gloria Luciani, Robin Fåhræus · 2002 · Nature Cell Biology
  37. Alternative splicing in cancer: implications for biology and therapy
    Justin Chen, William A. Weiss · 2014 · Oncogene
  38. Mechanisms underlying hypoxia-induced neuronal apoptosis
    Kenneth J. Banasiak, Ying Xia, Gabriel George Haddad · 2000 · Progress in Neurobiology
  39. Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy
    Pan, Rongqing, Ruvolo, Vivian, Mu, Hong, Leverson, Joel D., Nichols, Gwen, Reed, John C., Konopleva, Marina, Andreeff, Michael · 2017 · Cancer Cell
  40. DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization
    Sheau-Yann Shieh, Yoichi Taya, Carol Prives · 1999 · The EMBO Journal
  41. The Roles of MDM2 and MDMX in Cancer
    Orit Karni-Schmidt, Maria Lokshin, Carol L. Prives · 2016 · Annual Review of Pathology Mechanisms of Disease
  42. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase
    Sakaguchi, Kazuyasu, Saito, Shin'ichi, Higashimoto, Yuichiro, Roy, Siddhartha, Anderson, Carl W., Appella, Ettore · 2000 · Journal of Biological Chemistry
  43. Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation
    Feng, Jianhua, Tamaskovic, Rastislav, Yang, Zhongzhou, Brazil, Derek P., Merlo, Adrian, Hess, Daniel, Hemmings, Brian A. · 2004 · Journal of Biological Chemistry
  44. Cell-to-cell variation in p53 dynamics leads to fractional killing.
    Paek, Andrew L., Liu, Julia C., Loewer, Alexander, Forrester, William C., Lahav, Galit · 2016 · Cell
  45. The evolution of diverse biological responses to DNA damage: insights from yeast and p53
    Wahl, Geoffrey M., Carr, Antony M. · 2001 · Nature Cell Biology
  46. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes
    Michael R. Dohn, Shungzhen Zhang, Xinbin Chen · 2001 · Oncogene
  47. The multiple levels of regulation by p53 ubiquitination
    Lee, J T, Gu, W · 2010 · Cell Death & Differentiation
  48. Tumor suppressor genes and ROS: complex networks of interactions
    Beyza Vurusaner, Giuseppe Poli, Hüveyda Başağa · 2011 · Free Radical Biology and Medicine
  49. The Influence of Cell Cycle Regulation on Chemotherapy
    Ying Sun, Yang Liu, Xiaoli Ma, Hao Hu · 2021 · International Journal of Molecular Sciences
  50. NQO1 stabilizes p53 through a distinct pathway
    Asher, Gad, Lotem, Joseph, Kama, Rachel, Sachs, Leo, Shaul, Yosef · 2002 · Proceedings of the National Academy of Sciences
  51. p53 Family and Cellular Stress Responses in Cancer
    Johanna Pflaum, S Schlosser, Martina MÃ ⁄ ller · 2014 · Frontiers in Oncology
  52. Molecular pathogenesis of oral squamous carcinoma
    H K Williams · 2000 · Molecular Pathology
  53. Jun NH 2 -Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress
    Thomas Buschmann, Olga Potapova, Anat Bar‐Shira, Vladimir N. Ivanov, Serge Yu. Fuchs, Scott C. Henderson, Victor A. Fried, Toshinari Minamoto, Dania Alarcon-Vargas, Matthew R. Pincus et al. · 2001 · Molecular and Cellular Biology
  54. Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide
    Thomas, Douglas D., Espey, Michael Graham, Ridnour, Lisa A., Hofseth, Lorne J., Mancardi, Daniele, Harris, Curtis C., Wink, David A. · 2004 · Proceedings of the National Academy of Sciences
  55. Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin
    Diane L. Persons, Eugenia M. Yazlovitskaya, Jill C. Pelling · 2000 · Journal of Biological Chemistry
  56. Control of the cell cycle and apoptosis
    Robert A. Weinberg, Ante S. Lundberg · 1999 · European Journal of Cancer
  57. The INK4a/ARF tumor suppressor: one gene—two products—two pathways
    Lynda Chin, Jason H. Pomerantz, Ronald Anthony DePinho · 1998 · Trends in Biochemical Sciences
  58. The p16INK4a/CDKN2A tumor suppressor and its relatives
    Ruas, Margarida, Peters, Gordon · 1998 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  59. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Koichi Ichimura, Maria Bondesson, H. Goike, Esther Schmidt, Ahmad Moshref, V. Peter Collins · 2000 · PubMed
  60. Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein
    Sharp, Darcie A., Kratowicz, Stephen A., Sank, Michael J., George, Donna L. · 1999 · Journal of Biological Chemistry
  61. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
    Stevenson, Lauren F, Sparks, Alison, Allende‐Vega, Nerea, Xirodimas, Dimitris P, Lane, David P, Saville, Mark K · 2007 · The EMBO Journal
  62. Nucleolar Stress: hallmarks, sensing mechanism and diseases
    Kai Yang, Jie Yang, Jing Yi · 2018 · Cell Stress
  63. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
    Angela Reles, Wenhsiang Wen, Annette Schmider, Conway Gee, Ingo Bernard Runnebaum, Uta Kilian, Lovell Allan Jones, Adel K. El‐Naggar, Carmen Minguillon, I Schönborn et al. · 2001 · PubMed
  64. RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
    Moumen, Abdeladim, Masterson, Philip, O'Connor, Mark J., Jackson, Stephen P. · 2005 · Cell · Retracted
  65. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression
    Carroll, Patrick E, Okuda, Masaru, Horn, Henning F, Biddinger, Paul, Stambrook, Peter J, Gleich, Lyon L, Li, Ya-Qin, Tarapore, Pheruza, Fukasawa, Kenji · 1999 · Oncogene
  66. Cullin-RING Ligases as Attractive Anti-cancer Targets
    Yongchao Zhao, Yi Sun · 2013 · Current Pharmaceutical Design
  67. Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
    Gregg L. Semenza · 2001 · Pediatric Research
  68. To die or not to die: how does p53 decide?
    Elizabeth A. Slee, Daniel J O’Connor, Xin Lü · 2004 · Oncogene
  69. Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress
    Rintaro Okoshi, Toshinori Ozaki, Hideki Yamamoto, Kiyohiro Ando, Nami Koida, Sayaka Ono, Tadayuki Koda, Takehiko Kamijo, Akira Nakagawara, Harutoshi Kizaki · 2007 · Journal of Biological Chemistry
  70. Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1
    Ying Zhao, Shaoli Lu, Lipeng Wu, Guolin Chai, Haiying Wang, Yingqi Chen, Jia Teng Sun, Yu Yu, Wen Zhou, Quanhui Zheng et al. · 2006 · Molecular and Cellular Biology
  71. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma
    Sharon Barrans, Ian W.J. Carter, Roger G. Owen, Faith E. Davies, Russell D. Patmore, Andrew Haynes, Gareth John Morgan, Andrew Jack · 2002 · Blood
  72. Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’
    Satoshi Yamasaki, Naoko Yagishita, Takeshi Sasaki, Minako Nakazawa, Yukihiro Kato, Tadayuki Yamadera, Eun-Kyung Bae, Sayumi Toriyama, Rie Ikeda, Lei Zhang et al. · 2006 · The EMBO Journal
  73. Ubiquitination: Friend and foe in cancer
    Mohammed A. Mansour · 2018 · The International Journal of Biochemistry & Cell Biology
  74. Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex
    Jason D. Weber, Mei-Ling Kuo, Brian B. Bothner, Enrico L. DiGiammarino, Richard W. Kriwacki, Martine F. Roussel, Charles J. Sherr · 2000 · Molecular and Cellular Biology
  75. Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway
    M. Li, Zhuo Zhang, Donald L. Hill, Hui Wang, Ruiwen Zhang · 2007 · Cancer Research
  76. The complexity of TRIM28 contribution to cancer
    Patrycja Czerwińska, Sylwia Mazurek, Maciej Wiznerowicz · 2017 · Journal of Biomedical Science
  77. Rhabdomyosarcoma – working out the pathways
    Glenn T Merlino, Lee J. Helman · 1999 · Oncogene
  78. Mutant p53: an oncogenic transcription factor
    Sabrina Strano, Stefania Dell’Orso, Silvia Di Agostino, Giulia Fontemaggi, Ada Sacchi, Giovanni Blandino · 2007 · Oncogene
  79. SUMO-1 Modification of Mdm2 Prevents Its Self-Ubiquitination and Increases Mdm2 Ability to Ubiquitinate p53
    Thomas Buschmann, Serge Yu. Fuchs, Chee-Gun Lee, Zhen‐Qiang Pan, Ze’ev A. Ronai · 2000 · Cell · Retracted
  80. Reciprocal influence of the p53 and the hypoxic pathways
    Audrey Sermeus, Carine Michiels · 2011 · Cell Death and Disease
  81. Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
    Hua Mao, Drake G. LeBrun, Jingxuan Yang, Vivian F. Zhu, Min Li · 2012 · Cancer Investigation
  82. Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
    Christopher J. Lengner, Heather A. Steinman, James A. Gagnon, Thomas Wayne Smith, Janet E. Henderson, Barbara E. Kream, Gary S. Stein, Jane B. Lian, Stephen N. Jones · 2006 · The Journal of Cell Biology
  83. Regulation of p53 responses by post-translational modifications
    Yang Xu · 2003 · Cell Death and Differentiation
  84. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
    Meulmeester, Erik, Maurice, Madelon M., Boutell, Chris, Teunisse, Amina F.A.S., Ovaa, Huib, Abraham, Tsion E., Dirks, Roeland W., Jochemsen, Aart G. · 2005 · Molecular Cell
  85. p300/CBP/p53 interaction and regulation of the p53 response
    Steven R. Grossman · 2001 · European Journal of Biochemistry
  86. Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
    Kiyohiro Ando, Toshinori Ozaki, Hideki Yamamoto, Kazushige Furuya, Mitsuchika Hosoda, Syunji Hayashi, Masahiro Fukuzawa, Akira Nakagawara · 2004 · Journal of Biological Chemistry
  87. ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
    Stéphanie Courtois-Cox, Gerald W.C.T Verhaegh, Sophie North, Maria Gloria Luciani, Patrice Lassus, Urszula Hibner, Moshe Oren, Pierre L. Hainaut · 2002 · Oncogene
  88. Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
    Chad J. Creighton, Michael D. Fountain, Zhifeng Yu, Ankur K. Nagaraja, Huifeng Zhu, Mahjabeen Khan, Emuejevoke Olokpa, Azam Zariff, Preethi H. Gunaratne, Martin Matthew Matzuk et al. · 2010 · Cancer Research
  89. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
    Noa Furth, Yael Aylon · 2017 · Cell Death and Differentiation
  90. A critical role for telomeres in suppressing and facilitating carcinogenesis
    Artandi, Steven E, DePinho, Ronald A · 2000 · Current Opinion in Genetics & Development
  91. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts
    Stephen L. Lessnick, Caroline S. Dacwag, Todd R. Golub · 2002 · Cancer Cell
  92. Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen, Z Zhang, M. Li, W Wang, Ya Li, Elizabeth R. Rayburn, Donald L. Hill, Hui Wang, R Zhang · 2007 · Oncogene
  93. Ubiquitination and the Regulation of Membrane Proteins
    Natalie J. Foot, Tanya Lynn Henshall, Sharad Kumar · 2016 · Physiological Reviews
  94. The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells
    Andrea L. Talis, Jon M. Huibregtse, Peter M. Howley · 1998 · Journal of Biological Chemistry
  95. The Chaperone-associated Ubiquitin Ligase CHIP Is Able to Target p53 for Proteasomal Degradation
    Claudia Esser, Martin Scheffner, Jörg Höhfeld · 2005 · Journal of Biological Chemistry
  96. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells <i>in vivo</i>
    Francoz, Sarah, Froment, Pascal, Bogaerts, Sven, De Clercq, Sarah, Maetens, Marion, Doumont, Gilles, Bellefroid, Eric, Marine, Jean-Christophe · 2006 · Proceedings of the National Academy of Sciences
  97. The E2F transcription factors: key regulators of cell proliferation
    Heiko Müller, Kristian Helin · 2000 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  98. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis
    Simone E Salghetti, Masafumi Muratani, Herman Wijnen, Bruce Futcher, William P. Tansey · 2000 · Proceedings of the National Academy of Sciences
  99. MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
    Veronica Tisato, Rebecca Voltan, Arianna Gonelli, Paola Secchiero, Giorgio Zauli · 2017 · Journal of Hematology & Oncology
  100. p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1
    Jan Bohuslav, Lin‐Feng Chen, Hakju Kwon, Yajun Mu, Warner C. Greene · 2004 · Journal of Biological Chemistry